Senior Specialty Rep – Pharma Sales (VA Territory, Hybrid)

Amgen SA; Richmond (VA); Hybrid; USD 90,000 - 122,000; Full time

Benefits offered by this job

Retirement and Savings Plan

Health and welfare plans

Stock-based long-term incentives

Flexible work models (remote & hybrid)

Job summary

Amgen is seeking a Specialty Representative or Senior Specialty Representative in the United States. You will be the primary link to medical professionals, communicating clinical benefits and guiding them through payer dynamics.

You’ll implement marketing strategies, promote Amgen products, and work under the District Manager to hit territory targets. The role emphasizes field and virtual engagement, relationship-building, and a strong commitment to serving patients while upholding Amgen values.

Qualifications

• Bachelor's Degree OR
• Associate's degree and 4 years of Sales experience OR
• High school diploma/GED and 6 years of Sales experience

Responsibilities

• Provide clinical knowledge of Amgen's products to medical professionals
• Deliver branded sales messages and promotional programs to achieve territory sales targets
• Develop relationships to manage accounts and resolve reimbursement issues
• Provide feedback on marketing strategy and territory plans with the District Manager
• Collaborate with colleagues to share best practices and drive patient access

Skills

Sales experience

Relationship building

Communication skills

Clinical knowledge (pharma/healthcare)

Education

Bachelor's Degree

Associate's degree

High school diploma/GED

Job description

Amgen is seeking a Specialty Representative or Senior Specialty Representative in the United States. You will be the primary link to medical professionals, communicating clinical benefits and guiding them through payer dynamics.

You’ll implement marketing strategies, promote Amgen products, and work under the District Manager to hit territory targets. The role emphasizes field and virtual engagement, relationship-building, and a strong commitment to serving patients while upholding Amgen values.